HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

9.970

+0.2903.00%

Volume:8.29M

Turnover:82.85M

Market Cap:9.90B

PE:-30.37

High:10.150

Open:9.680

Low:9.680

Close:9.680

52wk High:18.750

52wk Low:1.130

Shares:993.00M

HK Float Shares:993.00M

Volume Ratio:1.03

T/O Rate:0.84%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.328

ROE:-12.77%

ROA:-12.32%

PB:4.85

PE(LYR):-30.37

PS:3833.48

Loading ...

Overview Company News Filings

Ascletis Pharma Completes Dosing in U.S. Clinical Trial for Obesity Treatment Combining ASC47 and Semaglutide

HK Movers | Pharma Stocks Shine. Luye Pharma up 8%; Hua Medicine, Hengrui Pharma up 7%; Sino Biopharm, Fudan Zhangjiang up over 3%

Tiger Newspress

HK Movers｜Biotech Stocks Gained. RemeGen, Junshi Bio And TigerMed Up 3%; Laekna And JW Therap Up 1%

Tiger Newspress

HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress

Ascletis Pharma Inc. Announces Dosing of First Participants in U.S. Phase IIa Study of Oral GLP-1R Agonist ASC30 for Obesity Treatment

Ascletis Pharma Faces Third-Party Challenge Over U.S. Patent Validity in Post Grant Review

Ascletis Pharma Inc. Announces First Participants Dosed in U.S. Phase I Clinical Trial of Potential Best-in-Class Psoriasis Treatment ASC50

HK Movers | HK's Biotech Shares Soar. JOINN Soars 8%; Fudan-Zhangjiang up 6%; HeartCare up 2%

Tiger Newspress

HK Movers | Biotech Stocks Jump. Canbridge Soars 40%; Ascletis Jumps 17%; TYK Medicines Gains 7%; HBM Holdings, Abbisko Up More Than 6%

Tiger Newspress

China's Biotech Moment Ignites a 60% Stock Rally That Beats AI

HK Movers｜Pharma Shares Rallied. Sino Biopharm Up 13%; Immunothech And Zai Lab Up 5%; Dualitybio And Grand Pharmaup 4%

Tiger Newspress

Ascletis Pharma Inc. Announces Poster Presentations on Study Results of GLP-1R Agonist ASC30 and Weight Loss Drug Candidate ASC47 at ADA Scientific Sessions

HK Movers｜Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.

Tiger Newspress

HK Movers｜HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%

Tiger Newspress

BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne

HK Movers｜Pharma Shares Jumped. Innovent Bio Up 15%; Zai Lab Up 5%; Junshi Bio And CSPC Pharma Up 4%

Tiger Newspress

Ascletis Pharma Announces Successful Phase III Trial of Denifanstat, a Groundbreaking Oral FASN Inhibitor for Acne Treatment

HK Movers｜HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%

Tiger Newspress

Ascletis Pharma Faces Legal Setback with Seven-Year Exclusion Order for ASC41 and ASC43F Drugs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01672/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":9.97,"timestamp":1759219684003,"preClose":9.68,"halted":0,"volume":8294900,"delay":0,"floatShares":993000000,"shares":993000000,"eps":-0.3282372247556496,"marketStatus":"Closed National Day","change":0.29,"latestTime":"09-30 16:08:04","open":9.68,"high":10.15,"low":9.68,"amount":82847832,"amplitude":0.048554,"askPrice":9.97,"askSize":8000,"bidPrice":9.94,"bidSize":19000,"shortable":3,"etf":0,"ttmEps":-0.28982318507595095,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1759368600000},"marketStatusCode":7,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":9.68,"openAndCloseTimeList":[[1759195800000,1759204800000],[1759208400000,1759219200000]],"volumeRatio":1.0340493686744254,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":993000000,"roa":"-12.32%","roe":"-12.77%","lyrEps":-0.328237,"volumeRatio":1.0340493686744254,"shares":993000000,"dividePrice":0,"high":10.15,"amplitude":0.048554,"preClose":9.68,"low":9.68,"week52Low":1.13,"pbRate":"4.85","psRate":"3833.48","week52High":18.75,"institutionHeld":0,"latestPrice":9.97,"committee":0.407407,"eps":-0.3282372247556496,"divideRate":0,"volume":8294900,"delay":0,"ttmEps":-0.28982318507595095,"open":9.68,"prevYearClose":3.01,"prevWeekClose":10.34,"prevMonthClose":9.97,"prevQuarterClose":9.97,"fiveDayClose":11.7,"twentyDayClose":13.94,"sixtyDayClose":8.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2025-08-15","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755221400000,"name":null,"time":"","dateTimestamp":1755187200000,"actualEps":null},{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-25","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-21","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.2,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1749830400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2025-09-30","current":-34.400284,"percent":0.029245,"low":-62.492237,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"high":-3.060869,"avg":-15.232158,"sd":9.246608,"marketCap":9901947970},"quantilePoints":[{"date":"2020-10-09","current":-27.562384,"twenty":-36.10597,"median":-32.357389,"eighty":-29.321809,"marketCap":3197311040},{"date":"2020-10-16","current":-29.275632,"twenty":-35.984854,"median":-32.259237,"eighty":-29.068393,"marketCap":3394658960},{"date":"2020-10-23","current":-29.488253,"twenty":-35.957754,"median":-32.073854,"eighty":-28.955111,"marketCap":3424613820},{"date":"2020-10-30","current":-26.437999,"twenty":-35.956418,"median":-32.003605,"eighty":-28.82979,"marketCap":3070846980},{"date":"2020-11-06","current":-26.60077,"twenty":-35.586274,"median":-31.898341,"eighty":-28.698509,"marketCap":3125880080},{"date":"2020-11-13","current":-26.110515,"twenty":-35.299289,"median":-31.691741,"eighty":-28.344195,"marketCap":3070846980},{"date":"2020-11-20","current":-26.400807,"twenty":-35.227708,"median":-31.598047,"eighty":-28.200646,"marketCap":3124460080},{"date":"2020-11-27","current":-25.996763,"twenty":-35.145931,"median":-31.506654,"eighty":-28.026747,"marketCap":3069451980},{"date":"2020-12-04","current":-26.063446,"twenty":-34.979619,"median":-31.354566,"eighty":-27.911719,"marketCap":3099467640},{"date":"2020-12-11","current":-26.31125,"twenty":-34.827046,"median":-31.274607,"eighty":-27.56687,"marketCap":3121449680},{"date":"2020-12-18","current":-27.740507,"twenty":-34.767763,"median":-31.233891,"eighty":-27.429855,"marketCap":3296346000},{"date":"2020-12-24","current":-26.603446,"twenty":-34.711392,"median":-31.107005,"eighty":-27.316987,"marketCap":3164492160},{"date":"2020-12-31","current":-26.500215,"twenty":-34.587018,"median":-31.004106,"eighty":-27.169357,"marketCap":3153504340},{"date":"2021-01-08","current":-25.623114,"twenty":-26.33735,"median":-26.070062,"eighty":-25.606579,"marketCap":3076589600},{"date":"2021-01-15","current":-26.301013,"twenty":-26.257669,"median":-26.058174,"eighty":-25.606579,"marketCap":3153504340},{"date":"2021-01-22","current":-27.687281,"twenty":-26.817021,"median":-26.133868,"eighty":-25.701626,"marketCap":3318321640},{"date":"2021-01-29","current":-25.459845,"twenty":-26.817021,"median":-26.18132,"eighty":-25.701626,"marketCap":3076589600},{"date":"2021-02-05","current":-26.710974,"twenty":-27.144116,"median":-26.500215,"eighty":-25.780011,"marketCap":3208443440},{"date":"2021-02-11","current":-26.94677,"twenty":-27.163157,"median":-26.50182,"eighty":-25.840901,"marketCap":3241406900},{"date":"2021-02-19","current":-29.217648,"twenty":-27.39605,"median":-26.606395,"eighty":-25.934212,"marketCap":3516102400},{"date":"2021-02-26","current":-27.726401,"twenty":-28.252216,"median":-26.780324,"eighty":-26.051041,"marketCap":3329309460},{"date":"2021-03-05","current":-26.695247,"twenty":-28.196164,"median":-26.801757,"eighty":-26.075007,"marketCap":3197455620},{"date":"2021-03-12","current":-27.661035,"twenty":-27.925684,"median":-26.796554,"eighty":-25.934212,"marketCap":3307333820},{"date":"2021-03-19","current":-27.578315,"twenty":-28.013713,"median":-26.946171,"eighty":-26.051041,"marketCap":3296346000},{"date":"2021-03-26","current":-26.684915,"twenty":-27.992927,"median":-26.925194,"eighty":-26.075007,"marketCap":3175479980},{"date":"2021-04-01","current":-12.856888,"twenty":-27.937324,"median":-26.841361,"eighty":-25.906193,"marketCap":3186467800},{"date":"2021-04-09","current":-12.651626,"twenty":-27.902405,"median":-26.79135,"eighty":-25.749374,"marketCap":3142516520},{"date":"2021-04-16","current":-12.515766,"twenty":-27.83964,"median":-26.703111,"eighty":-25.606579,"marketCap":3120540880},{"date":"2021-04-23","current":-12.748275,"twenty":-27.761167,"median":-26.610487,"eighty":-20.3699,"marketCap":3186467800},{"date":"2021-04-30","current":-12.958615,"twenty":-27.702929,"median":-26.546385,"eighty":-12.849963,"marketCap":3252394720},{"date":"2021-05-07","current":-13.875629,"twenty":-27.671533,"median":-26.500215,"eighty":-12.917924,"marketCap":3505114580},{"date":"2021-05-14","current":-13.623513,"twenty":-27.632266,"median":-26.264893,"eighty":-13.033167,"marketCap":3439187660},{"date":"2021-05-21","current":-13.663274,"twenty":-27.599178,"median":-26.114327,"eighty":-13.140261,"marketCap":3450175480},{"date":"2021-05-28","current":-15.770587,"twenty":-27.536493,"median":-26.046286,"eighty":-13.276483,"marketCap":4021542120},{"date":"2021-06-04","current":-14.720056,"twenty":-27.44752,"median":-25.775671,"eighty":-13.355805,"marketCap":3735858800},{"date":"2021-06-11","current":-16.063352,"twenty":-27.383939,"median":-25.742295,"eighty":-13.363408,"marketCap":4076481220},{"date":"2021-06-18","current":-14.31767,"twenty":-27.321052,"median":-25.623114,"eighty":-13.37885,"marketCap":3604004960},{"date":"2021-06-25","current":-15.287624,"twenty":-27.213321,"median":-25.50862,"eighty":-13.470373,"marketCap":3845737000},{"date":"2021-07-02","current":-15.35814,"twenty":-27.20728,"median":-21.095972,"eighty":-13.623513,"marketCap":3856724820},{"date":"2021-07-09","current":-15.855335,"twenty":-27.138398,"median":-16.377335,"eighty":-13.663274,"marketCap":3977590840},{"date":"2021-07-16","current":-14.892058,"twenty":-27.096973,"median":-16.253526,"eighty":-13.686225,"marketCap":3735858800},{"date":"2021-07-23","current":-14.192621,"twenty":-26.97726,"median":-16.035624,"eighty":-13.755247,"marketCap":3560053680},{"date":"2021-07-30","current":-12.791706,"twenty":-26.94677,"median":-15.809995,"eighty":-13.432088,"marketCap":3219431260},{"date":"2021-08-06","current":-12.341273,"twenty":-26.946171,"median":-15.662682,"eighty":-13.226349,"marketCap":3098565240},{"date":"2021-08-13","current":-12.368185,"twenty":-26.904217,"median":-15.576148,"eighty":-12.99939,"marketCap":3109553060},{"date":"2021-08-20","current":-11.921226,"twenty":-26.880965,"median":-15.419458,"eighty":-12.856888,"marketCap":2988687040},{"date":"2021-08-27","current":-9.483763,"twenty":-26.801757,"median":-15.385644,"eighty":-12.791706,"marketCap":3065601780},{"date":"2021-09-03","current":-9.989583,"twenty":-26.79135,"median":-15.321348,"eighty":-12.740344,"marketCap":3230419080},{"date":"2021-09-10","current":-10.099521,"twenty":-26.758891,"median":-15.242013,"eighty":-12.683051,"marketCap":3274370360},{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500},{"date":"2025-04-11","current":-16.143826,"twenty":-25.799935,"median":-13.637196,"eighty":-7.037853,"marketCap":5154695920},{"date":"2025-04-17","current":-14.844692,"twenty":-25.761244,"median":-13.643555,"eighty":-7.040226,"marketCap":4751255705},{"date":"2025-04-25","current":-18.855479,"twenty":-25.629177,"median":-13.630838,"eighty":-7.035481,"marketCap":6040177180},{"date":"2025-05-02","current":-19.624433,"twenty":-25.555188,"median":-13.637196,"eighty":-7.037853,"marketCap":6299866327},{"date":"2025-05-09","current":-19.687295,"twenty":-25.378575,"median":-13.630838,"eighty":-7.035481,"marketCap":6364413943},{"date":"2025-05-16","current":-16.189425,"twenty":-25.028984,"median":-13.630838,"eighty":-7.035481,"marketCap":5276397641},{"date":"2025-05-23","current":-19.381154,"twenty":-24.642413,"median":-13.630838,"eighty":-7.035481,"marketCap":6335528555},{"date":"2025-05-30","current":-22.492822,"twenty":-24.315979,"median":-13.630838,"eighty":-7.035481,"marketCap":7385031005},{"date":"2025-06-06","current":-22.37708,"twenty":-24.163622,"median":-13.630838,"eighty":-7.035481,"marketCap":7365774080},{"date":"2025-06-13","current":-27.602111,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9089268930},{"date":"2025-06-20","current":-28.183664,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9262581261},{"date":"2025-06-27","current":-25.15423,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8290106513},{"date":"2025-07-04","current":-27.519363,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9070012004},{"date":"2025-07-11","current":-25.909492,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8530818085},{"date":"2025-07-18","current":-34.00727,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11188273831},{"date":"2025-07-25","current":-31.259636,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10321712175},{"date":"2025-08-01","current":-30.808479,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10109885992},{"date":"2025-08-08","current":-40.038892,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13171737178},{"date":"2025-08-15","current":-51.999696,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17080893095},{"date":"2025-08-22","current":-50.820081,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14298267332},{"date":"2025-08-29","current":-48.026994,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13576938778},{"date":"2025-09-05","current":-47.125793,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13308972881},{"date":"2025-09-12","current":-39.078151,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11056074414},{"date":"2025-09-19","current":-37.494834,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10600591060},{"date":"2025-09-26","current":-36.39561,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10263119060},{"date":"2025-09-30","current":-35.039629,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9901947970}],"updateTime":1759323596616},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551395411","title":"Ascletis Pharma Completes Dosing in U.S. Clinical Trial for Obesity Treatment Combining ASC47 and Semaglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2551395411","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551395411?lang=en_us&edition=fundamental","pubTime":"2025-07-15 06:51","pubTimestamp":1752533493,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced the completion of dosing for all participants in its U.S. clinical study that combines the adipose-targeted, once-monthly injectable small molecule THR-beta agonist, ASC47, with semaglutide for the treatment of obesity. The study, identified as ASC47-103 , involves a randomized, double-blind, placebo-controlled design and includes 28 participants without type 2 diabetes. The participants are divided into three cohorts, receiving single ascending doses of ASC47  or a placebo, along with four doses of semaglutide . The enrollment process was completed in less than two months. Ascletis plans to present topline data from the trial in the fourth quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL6Kd4cT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01672","BK1574","BK1161"],"gpt_icon":0},{"id":"1102485960","title":"HK Movers | Pharma Stocks Shine. Luye Pharma up 8%; Hua Medicine, Hengrui Pharma up 7%; Sino Biopharm, Fudan Zhangjiang up over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102485960","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102485960?lang=en_us&edition=fundamental","pubTime":"2025-07-09 10:31","pubTimestamp":1752028303,"startTime":"0","endTime":"0","summary":"Hong Kong’s pharma stocks shined on Wednesday. Luye Pharma up 8%; Hua Medicine, Hengrui Pharma up 7%; Sino Biopharm, Fudan Zhangjiang up over 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"36aa7b3b0e5d12a0b0767a4494ad1a18","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","02137","09606","02359","09966","02268","06978","01672","02269","03759","09995","03347","09688"],"gpt_icon":0},{"id":"1178506344","title":"HK Movers｜Biotech Stocks Gained. RemeGen, Junshi Bio And TigerMed Up 3%; Laekna And JW Therap Up 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178506344","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178506344?lang=en_us&edition=fundamental","pubTime":"2025-07-08 09:48","pubTimestamp":1751939304,"startTime":"0","endTime":"0","summary":"Biotech stocks gained. RemeGen, Junshi Bio and TigerMed up 3%; Laekna and JW Therap up 1%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","02269","01672","09688","09966","06978","03347","02268","06606","02359","09995","02137","09606"],"gpt_icon":0},{"id":"1109523465","title":"HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109523465","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109523465?lang=en_us&edition=fundamental","pubTime":"2025-07-03 11:00","pubTimestamp":1751511647,"startTime":"0","endTime":"0","summary":"HK Innovative Drug Concept Stocks Rose. Biostar up 15%; Akeso up 11%; SKB Bio and Innovent Bio up more than 7%; Zai Lab up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8f9423fb69201ea469acc4a9341fc19e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","09606","09966","03347","06990","01801","02268","09688","09926","02359","06978","01672","02563","06606","02137","03759","09995"],"gpt_icon":0},{"id":"2548845559","title":"Ascletis Pharma Inc. Announces Dosing of First Participants in U.S. Phase IIa Study of Oral GLP-1R Agonist ASC30 for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2548845559","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548845559?lang=en_us&edition=fundamental","pubTime":"2025-07-03 06:47","pubTimestamp":1751496453,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. Announces Dosing of First Participants in U.S. Phase IIa Study of Oral GLP-1R Agonist ASC30 for Obesity Treatment. Ascletis Pharma Inc. has announced the commencement of a U.S. 13-week Phase IIa study involving participants with obesity or overweight, who have been dosed with the small molecule oral GLP-1 receptor agonist, ASC30. This investigational drug, designed for once-daily oral or once-monthly subcutaneous administration, demonstrated a placebo-adjusted mean body weight reduction of up to 6.5% from baseline after four weeks in a previous Phase Ib study. Topline data from the current Phase IIa study are expected to be presented in the fourth quarter of 2025. ASC30 is a new chemical entity with patent protection in the U.S. and globally until 2044.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDLWwwgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"2547657035","title":"Ascletis Pharma Faces Third-Party Challenge Over U.S. Patent Validity in Post Grant Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2547657035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547657035?lang=en_us&edition=fundamental","pubTime":"2025-06-30 08:04","pubTimestamp":1751241847,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced that a petition for Post Grant Review has been filed with the United States Patent and Trademark Office by Conjupro Biotherapeutics, Inc., a subsidiary of CSPC Pharmaceutical Group Limited. The petition challenges the validity of specific claims in one of Ascletis Pharma's granted U.S. patents. The patent in question covers the molecular structure of Compound 1, which is identical to Compound 10 in CSPC's pending patent application. Ascletis had filed its patent application approximately three months before CSPC's application. The petition is currently under review by the USPTO, and its potential impact on Ascletis cannot be determined at this stage. The company will monitor developments closely and inform shareholders and investors of any significant updates.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL1QL1hB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091754.HKD","LU1807302812.USD","LU1993786604.SGD","LU1152091168.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU1008478684.HKD","BK1515","LU1226287529.USD","LU1226287875.USD","01672","LU1960683339.HKD","IE00B031HY20.USD","LU1226288170.HKD","01093","IE00BZ08YR35.GBP","IE0008368742.USD","BK1191","IE00B543WZ88.USD","LU0880133367.SGD","BK1574","LU1226287792.SGD","IE0008369823.USD","LU1951186391.HKD","LU0326950275.SGD","IE00BZ08YT58.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU0072913022.USD","BK1161","LU0501845795.SGD","SG9999004220.SGD","LU1226288253.USD","BK1521"],"gpt_icon":0},{"id":"2544919934","title":"Ascletis Pharma Inc. Announces First Participants Dosed in U.S. Phase I Clinical Trial of Potential Best-in-Class Psoriasis Treatment ASC50","url":"https://stock-news.laohu8.com/highlight/detail?id=2544919934","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544919934?lang=en_us&edition=fundamental","pubTime":"2025-06-18 07:49","pubTimestamp":1750204152,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. Announces First Participants Dosed in U.S. Phase I Clinical Trial of Potential Best-in-Class Psoriasis Treatment ASC50. Ascletis Pharma Inc. has announced the dosing of the first participants in its U.S. Phase I clinical trial of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor for the treatment of psoriasis. This trial is designed to assess the safety, tolerability, and preliminary efficacy of ASC50. Preclinical data, showing higher oral exposure, longer half-life, and strong efficacy, suggest ASC50 could be a leading once-daily oral treatment option for psoriasis. The trial is randomized, double-blind, and placebo-controlled, involving both healthy participants and patients with mild-to-moderate plaque psoriasis. The results of this study are expected to be presented in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDLbmXbJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"1176260919","title":"HK Movers | HK's Biotech Shares Soar. JOINN Soars 8%; Fudan-Zhangjiang up 6%; HeartCare up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176260919","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176260919?lang=en_us&edition=fundamental","pubTime":"2025-06-17 10:13","pubTimestamp":1750126422,"startTime":"0","endTime":"0","summary":"Hong Kong’s biotech stocks rose on Tuesday.JOINN soared 8%; Fudan-Zhangjiang rose 6%; HeartCare rose 2%; CANbridge, Ascentage, WuXi XDC rose 1%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b1241f583e82227963a979cc1445c279","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","03759","06127","09966","02137","09606","03347","02268","01349","06978","02359","06606","09688","01228","02269","06609","01672"],"gpt_icon":0},{"id":"1194995839","title":"HK Movers | Biotech Stocks Jump. Canbridge Soars 40%; Ascletis Jumps 17%; TYK Medicines Gains 7%; HBM Holdings, Abbisko Up More Than 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194995839","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194995839?lang=en_us&edition=fundamental","pubTime":"2025-06-16 11:22","pubTimestamp":1750044159,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped on Monday. Canbridge soared 40%; Ascletis jumped 17%; TYK Medicines gained 7%; HBM Holdings, Abbisko up more than 6%.China’s biotechnology stocks have shaken off a four-year slum","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"972a3d1b12236587576f532fe6844297","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","06978","09606","06606","02359","03347","09966","09995","02137","02268","09688","03759","01672"],"gpt_icon":0},{"id":"1112671838","title":"China's Biotech Moment Ignites a 60% Stock Rally That Beats AI","url":"https://stock-news.laohu8.com/highlight/detail?id=1112671838","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112671838?lang=en_us&edition=fundamental","pubTime":"2025-06-15 17:06","pubTimestamp":1749978383,"startTime":"0","endTime":"0","summary":"China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping further gains.The Hang Seng Biotech Index has surged more than","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"lsy1584095487587","url":"https://www.bloomberg.com/news/articles/2025-06-15/china-s-biotech-moment-ignites-a-60-stock-rally-that-beats-ai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"837a503644945598b4960c4027e80bcb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-06-15/china-s-biotech-moment-ignites-a-60-stock-rally-that-beats-ai","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["09688","06606","09995","02268","02137","03759","03347","06978","09606","02269","02359","09966","01672"],"gpt_icon":1},{"id":"1153010109","title":"HK Movers｜Pharma Shares Rallied. Sino Biopharm Up 13%; Immunothech And Zai Lab Up 5%; Dualitybio And Grand Pharmaup 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153010109","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153010109?lang=en_us&edition=fundamental","pubTime":"2025-06-12 09:38","pubTimestamp":1749692325,"startTime":"0","endTime":"0","summary":"Pharma Shares Rallied. Sino Biopharm up 13%; Immunothech and Zai Lab up 5%; Dualitybio and Grand Pharmaup 4%; Ascletis, Remegen and Beigene up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a033ddb9c054b7a11d6c94b371cfc285","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","02137","09606","02359","09966","02268","06978","01672","02269","03759","09995","03347","09688"],"gpt_icon":0},{"id":"2542822731","title":"Ascletis Pharma Inc. Announces Poster Presentations on Study Results of GLP-1R Agonist ASC30 and Weight Loss Drug Candidate ASC47 at ADA Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2542822731","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542822731?lang=en_us&edition=fundamental","pubTime":"2025-06-09 08:04","pubTimestamp":1749427464,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. Announces Poster Presentations on Study Results of GLP-1R Agonist ASC30 and Weight Loss Drug Candidate ASC47 at ADA Scientific Sessions. Ascletis Pharma Inc. has announced that it will present the study results of two drug candidates, ASC30 and ASC47, at the 85th Scientific Sessions of the American Diabetes Association  in Chicago, U.S., scheduled from June 20 to 23, 2025. The presentations will include a poster on ASC30, an oral GLP-1R small molecule agonist, which is the subject of a first-in-human single ascending dose study in participants with obesity. Additionally, a separate poster will feature ASC47, a muscle-preserving weight loss drug candidate, which demonstrated superior weight loss in combination with Semaglutide compared to Semaglutide monotherapy in a preclinical model. Both presentations are set for June 22, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL1wQQy9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0},{"id":"1102844514","title":"HK Movers｜Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102844514","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102844514?lang=en_us&edition=fundamental","pubTime":"2025-06-06 14:14","pubTimestamp":1749190451,"startTime":"0","endTime":"0","summary":"HK pharma shares rallied. CSPC Pharma up 9%; 3SBio up 4%; Yihai up 3%; Genscript Bio and JXR up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"691e120ad0cf34ff3123a3b2b155f5fc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","09606","09966","06606","09688","09995","03347","02268","02269","06978","02137","01672","03759"],"gpt_icon":0},{"id":"1147990132","title":"HK Movers｜HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147990132","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147990132?lang=en_us&edition=fundamental","pubTime":"2025-06-05 10:17","pubTimestamp":1749089820,"startTime":"0","endTime":"0","summary":"HK pharma shares kept rally. Zai Lab up 7%; Hutchmed up 6%; Immunotech up 5%; Sihuan Pharm, Akeso and Genscript Bio up 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","09688","09995","02268","09606","01672","03347","06978","03759","09966","02269","02359","02137"],"gpt_icon":0},{"id":"2540055112","title":"BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2540055112","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540055112?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:27","pubTimestamp":1749029233,"startTime":"0","endTime":"0","summary":"BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China** Shares of drug developer Sagimet Biosciences SGMT.O rise 52% to $5.53 premarket** SGMT says its oral acne drug, denifanstat, met the main goals in a late-stage trial conducted by its Chinese partner Ascletis 1672.HK** Denifanstat showed 33.2% treatment success rate versus 14.6% for placebo** Denifanstat works by inhibiting the production of sebum, a key contributor to acne, through a novel mechanism of action, co says** The drug reduced total acne lesions by 57.4% compared to 35.4% with placebo** Ascletis plans to submit denifanstat for approval to Chinese regulators** As of last close, stock down 19.3% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL3N3S70LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK4139","SGMT","BK1161","01672"],"gpt_icon":0},{"id":"2540053848","title":"Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2540053848","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540053848?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:00","pubTimestamp":1749027616,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, announced the positive results of a Phase 3 clinical trial conducted by its license partner, Ascletis Bioscience Co. Ltd. in China, for the treatment of moderate to severe acne vulgaris. The trial evaluated the oral small molecule fatty acid synthase  inhibitor, denifanstat, which met all primary and secondary endpoints versus a placebo and was well tolerated by participants. This development marks an advancement in acne treatment, introducing a novel mechanism of action through FASN inhibition. Additionally, Sagimet has initiated a Phase 1 clinical trial in the United States for a second FASN inhibitor, TVB-3567, targeting acne treatment. The positive outcomes from the trial underscore the potential of FASN inhibition as a therapeutic approach for acne.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9NgkYx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","BK1161","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","BK4588","01672","IE00BKPKM429.USD","SGMT","BK1574","BK1515","NDAQ","IE00B3QW5Z07.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"1129441589","title":"HK Movers｜Pharma Shares Jumped. Innovent Bio Up 15%; Zai Lab Up 5%; Junshi Bio And CSPC Pharma Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129441589","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129441589?lang=en_us&edition=fundamental","pubTime":"2025-06-04 09:41","pubTimestamp":1749001285,"startTime":"0","endTime":"0","summary":"HK's Pharma Shares Jumped. Innovent Bio up 15%; Zai Lab up 5%; Junshi Bio and CSPC Pharma up 4%; TigerMed and Innocare up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"dbe3c8968315be1dd8b4bc2e812eb0a3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","02137","09606","01672","09966","03347","02359","02268","03759","09995","06606","09688","06978"],"gpt_icon":0},{"id":"2540088442","title":"Ascletis Pharma Announces Successful Phase III Trial of Denifanstat, a Groundbreaking Oral FASN Inhibitor for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540088442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540088442?lang=en_us&edition=fundamental","pubTime":"2025-06-04 07:15","pubTimestamp":1748992517,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced that its Phase III clinical trial for denifanstat , a first-in-class, once-daily oral fatty acid synthase  inhibitor, has met all primary, key secondary, and secondary endpoints for the treatment of moderate to severe acne vulgaris. The randomized, double-blind, placebo-controlled, multicenter trial conducted in China involved 480 patients. Denifanstat demonstrated a statistically significant improvement in treatment outcomes, with a 33.2% treatment success rate and reductions in total, inflammatory, and non-inflammatory lesion counts by 57.4%, 63.5%, and 51.9% respectively, compared to baseline. The trial results indicate that denifanstat was more effective than several FDA-approved acne treatments in placebo-adjusted percent treatment success. The drug maintained a favorable safety and tolerability profile throughout the study. Ascletis plans to submit the treatment for approval by the China National Medical Products Administration .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL63QMGf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"1122993430","title":"HK Movers｜HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122993430","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122993430?lang=en_us&edition=fundamental","pubTime":"2025-06-03 09:40","pubTimestamp":1748914817,"startTime":"0","endTime":"0","summary":"HK's pharma shares jumped. Medlive up 8%; Sihuan Pharm and Junshi Bio up 7%; Pharmaron and Fosun Pharma up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ca7f89e3633e9b2b6f9adb0439901331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","09606","09966","06606","09688","09995","03347","02268","02269","06978","02137","01672","03759"],"gpt_icon":0},{"id":"2539275394","title":"Ascletis Pharma Faces Legal Setback with Seven-Year Exclusion Order for ASC41 and ASC43F Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2539275394","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539275394?lang=en_us&edition=fundamental","pubTime":"2025-05-30 22:43","pubTimestamp":1748616210,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has been involved in legal proceedings with Viking Therapeutics, Inc. over the importation of its drug candidates, ASC41 and ASC43F. In October 2024, the United States International Trade Commission issued an initial determination finding a violation of Section 337, recommending a seven-year exclusion order for these drugs. ASC41 is developed for treating non-alcoholic steatohepatitis  and targets thyroid hormone receptor beta , while ASC43F is a fixed-dose combination targeting both THRβ and farnesoid X receptor  for NASH treatment. Despite the ruling, Ascletis believes the outcome will not have a material adverse effect on its business and is seeking legal advice for an appeal. The company is committed to protecting its trade secrets and will provide updates on any significant developments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL48bdv9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX","BK1161","BK4139","BK1515","BK4585","BK1574","01672","BK4588","BK4599"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":96,"code":"91000000","status":"200"}]}}